.jpg)
.png)
TOPLINE: Inotuzumab ozogamicin (IO), an anti‐CD22 antibody conjugated with calicheamicin, was well tolerated and demonstrated an overall response rate of 74% in adult patients with relapsed/refractory B-cell acute lymphoblastic leukaemia (B-ALL) in a real-world study. METHODOLOGY: Researchers conducted a multicentre retrospective cohort study involving 73 adult patients (median age at IO initiation...
???? Are You a Music Artist Ready to Be Heard? ????
It’s time to stop playing around and get your music on real radio. Join a platform that truly supports artists and gives you the exposure you deserve.
SugarWaterRadio is changing the game—one song at a time.
Get real airplay, real listeners, and real results.
???? Submit your music now at SugarWaterRadio.com
Let’s make your dream a reality.
CLICK HERE & TURN UP YOUR FUTURE! ????
Copyright © 2023 swsports. All Rights Reserved
